Optimizing the Care of Patients Receiving CAR T-Cell Therapy
Patients with relapsed or refractory hematologic disorders like acute lymphoblastic leukemia and diffuse large B-cell lymphoma have poor outcomes and require novel effective therapies.
Category
  • Acute Lymphoblastic Leukemia
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Strategies to Identify Needs and Coordinate Referrals to a Multidisciplinary Chronic Graft-Versus-Host Disease Clinic
Chronic graft-versus-host disease (GVHD) is a potentially serious complication that significantly impacts quality of life in patients undergoing allogeneic hematopoietic cell transplant.  Treatment of chronic GVHD can be optimized by providing coordinated care involving a multidisciplinary t
Category
  • Hematologic Malignancies
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Transition of Care: Homebound Hematopoietic Cell Transplantation
Hematopoietic cell transplant (HCT) in an outpatient setting requires well-defined coordinated care by a dedicated team including transplant physician, oncology nurse with expertise in caring for patients receiving HCT, and a competent full-time caregiver.
Category
  • Hematologic Malignancies
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Patient Case Studies and Panel Discussion: Lymphoma
Although advances in treatment options for patients with hematologic malignancies are encouraging, the rapidly changing scientific and clinical environment represents a daunting challenge for practitioners.
Category
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Updates in the Management of CLL: Histologic Transformation and Relapsed/Refractory Disease
Histologic transformation of chronic lymphocytic leukemia (CLL) to more aggressive lymphoma is associated with a poor prognosis since it is typically resistant to standard chemoimmunotherapy regimens used for the treatment of CLL.
Category
  • Chronic Lymphocytic Leukemia
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Updates to Front-line Therapy in Hodgkin Lymphoma
Patients with advanced Hodgkin lymphoma (HL) have limited options.
Category
  • Hodgkin Lymphoma
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Emerging Options for the Management of Relapsed/Refractory Hodgkin Lymphoma
Patients with relapsed or refractory Hodgkin lymphoma (R/R HL) have limited therapeutic options, which are further narrowed once they become unresponsive to stem cell transplant.
Category
  • Hodgkin Lymphoma
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Insights - Cancer-Associated Venous Thromboembolic Disease, Version 2.2018
Venous thromboembolism (VTE) is common in patients with cancer and increases morbidity and mortality. VTE prevention and treatment are more complex in patients with cancer.
Category
  • Venous Thromboembolic Disease
Format
  • Monograph/Journal Supplement
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Safe Handling of Chemotherapy
Join Katie Gauen, PharmD, from Robert H. Lurie Comprehensive Cancer Center of Northwestern University for this webinar in the 2018 NCCN Pharmacy Update Series on the topic of Safe Handling of Chemotherapy.
Category
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN 2018 Congress Webinar Series: Acute Leukemia - Impact of Changing Molecular Landscape on Leukemia Management
The goal of this activity is to ensure that members of the multidisciplinary oncology care team, including physicians, nurses, pharmacists and other relevant health care professionals, have the knowledge and skills necessary to apply the new standards of care for patients with an acute leukemia.
Category
  • Acute Lymphoblastic Leukemia
  • Acute Myelogenous Leukemia
Format
  • Recorded Webcast
Credits
  • ABIM MOC
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages